journal article·2017-01Open access

Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy

Wei Li, Dongfei Liu, Hongbo Zhang, Alexandra Correia, Ermei Mäkilä, Jarno Salonen, Jouni Hirvonen, Hélder A. Santos

Acta Biomaterialia· Volume 48

Abstract

Harsh conditions of the gastrointestinal tract hinder the oral delivery of many drugs. Developing oral drug delivery systems based on commercially available materials is becoming more challenging due to the demand for simultaneously delivering physicochemically different drugs for treating complex diseases. A novel architecture, namely nanotube-in-microsphere, was developed as a drug delivery platform by encapsulating halloysite nanotubes (HNTs) in a pH-responsive hydroxypropyl methylcellulose acetate succinate polymer using microfluidics. HNTs were selected as orally acceptable clay mineral and their lumen was enlarged by selective acid etching. Model drugs (atorvastatin and celecoxib) with different physicochemical properties and synergistic effect on colon cancer prevention and inhibition were simultaneously incorporated into the microspheres at a precise ratio, with atorvastatin and celecoxib being loaded in the HNTs and polymer matrix, respectively. The microspheres showed spherical shape, narrow particle size distribution and pH-responsive dissolution behavior. This nanotube/pH-responsive polymer composite protected the loaded drugs from premature release at pH⩽6.5, but allowed their fast release and enhanced the drug permeability, and the inhibition of colon cancer cell proliferation at pH 7.4. Overall, the nano-in-micro drug delivery composite fabricated by microfluidics is a promising and flexible platform for the delivery of multiple drugs for combination therapy. Statement of significance Halloysite nanotubes (HNTs) are attracting increasing attention for drug delivery applications. However, conventional HNTs-based oral drug delivery systems are lack of the capability to precisely control the drug release at a desired site in the gastrointestinal tract. In this study, a nanotube-in-microsphere drug delivery platform is developed by encapsulating HNTs in a pH-responsive polymer using microfluidics. Drugs with different physicochemical properties and synergistic effect on colon cancer therapy were simultaneously incorporated in the microspheres. The prepared microspheres prevented the premature release of the loaded drugs after exposure to the harsh conditions of the gastrointestinal tract, but allowed their simultaneously fast release, and enhanced the drug permeability and the inhibition of colon cancer cell proliferation in response to the colon pH.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Mesoporous Materials and Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Oral delivery of anticancer drugs: challenges and opportunities10.1016/j.jconrel.2013.04.020 ↗
2. Challenges for the oral delivery of macromolecules10.1038/nrd1067 ↗
3. Chitosan-alginate microcapsules provide gastric protection and intestinal release of ICAM-1-targeting nanocarriers, enabling gi targeting in vivo10.1002/adfm.201600084 ↗
4. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine10.1016/j.biomaterials.2013.08.035 ↗
5. Fabrication of a multifunctional nano-in-micro drug delivery platform by microfluidic templated encapsulation of porous silicon in polymer matrix10.1002/adma.201400953 ↗
6. Micro/nanofabricated platforms for oral drug delivery10.1016/j.jconrel.2015.07.033 ↗
7. Halloysite clay nanotubes for loading and sustained release of functional compounds10.1002/adma.201502341 ↗
8. Halloysite nanotubes capturing isotope selective atmospheric CO210.1038/srep08711 ↗
9. Highly-controllable imprinted polymer nanoshell at the surface of magnetic halloysite nanotubes for selective recognition and rapid adsorption of tetracycline10.1039/c3ra45779f ↗
10. Electrospun microfiber membranes embedded with drug-loaded clay nanotubes for sustained antimicrobial protection10.1021/nn506255e ↗
11. Clay nanotube-biopolymer composite scaffolds for tissue engineering10.1039/C6NR00641H ↗
12. Controlled release and antibacterial activity of antibiotic-loaded electrospun halloysite/poly(lactic-co-glycolic acid) composite nanofibers10.1016/j.colsurfb.2013.04.036 ↗
13. Chitosan-halloysite nanotubes nanocomposite scaffolds for tissue engineering10.1039/c3tb20084a ↗
14. Halloysite clay nanotubes for controlled release of protective agents10.1021/nn800259q ↗
15. Electrospun poly(lactic-co-glycolicacid)/halloysite nanotube composite nanofibers for drug encapsulation and sustained release10.1039/c0jm01328e ↗
16. Electrophoretic deposition of polyacrylic acid and composite films containing nanotubes and oxide particles10.1016/j.jcis.2011.07.007 ↗
17. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells10.1016/j.jconrel.2012.02.018 ↗
18. Halloysite clay nanotubes for resveratrol delivery to cancer cells10.1002/mabi.201200121 ↗
19. Enzyme-activated intracellular drug delivery with tubule clay nanoformulation10.1038/srep10560 ↗
20. Cytocompatibility and uptake of halloysite clay nanotubes10.1021/bm9014446 ↗
21. In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes10.1016/j.colsurfb.2015.07.021 ↗
22. Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-culture10.1002/jat.2858 ↗
23. Adsorption of modified halloysite nanotubes in vitro and the protective effect in rats exposed to zearalenone10.1080/1745039X.2014.927710 ↗
24. Gamma-aminobutyric acid loaded halloysite nanotubes and in vitro-in vivo evaluation for brain delivery10.1016/j.ijpharm.2015.08.087 ↗
25. Ecotoxicity of halloysite nanotube–supported palladium nanoparticles in Raphanus sativus L10.1002/etc.3412 ↗
26. Evaluation of toxicity of nanoclays and graphene oxide in vivo: a Paramecium caudatum study10.1039/C5EN00201J ↗
27. Functionalized halloysite nanotube by chitosan grafting for drug delivery of curcumin to achieve enhanced anticancer efficacy10.1039/C5TB02725J ↗
28. Toxicity of halloysite clay nanotubes in vivo: a Caenorhabditis elegans study10.1039/C4EN00135D ↗
29. Halloysite clay nanotubes for enzyme immobilization10.1021/acs.biomac.5b01542 ↗
30. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral10.1080/02652040010019532 ↗
31. In situ generation of sodium alginate/hydroxyapatite/halloysite nanotubes nanocomposite hydrogel beads as drug-controlled release matrices10.1039/c3tb20971g ↗
32. On prilled nanotubes-in-microgel oral systems for protein delivery10.1016/j.ejpb.2016.01.014 ↗
33. Enlargement of halloysite clay nanotube lumen by selective etching of aluminum oxide10.1021/nn302328x ↗
34. A ceramic drug delivery vehicle for oral administration of highly potent opioids10.1002/jps.21814 ↗
35. The application of halloysite tubule nanoclay in drug delivery10.1517/17425247.2016.1169271 ↗
36. Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery10.1002/smll.201303740 ↗
37. Microfluidic manipulation of core/shell nanoparticles for oral delivery of chemotherapeutics: a new treatment approach for colorectal cancer10.1002/adma.201502697 ↗
38. A. Novel protease inhibitor-loaded nanoparticle-in-microparticle delivery system leads to a dramatic improvement of the oral pharmacokinetics in dogs10.1016/j.biomaterials.2014.10.026 ↗
39. Facile preparation of multifunctional superparamagnetic PHBV microspheres containing SPIONs for biomedical applications10.1038/srep23140 ↗
40. Mesoporous silicon-PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering10.1002/adfm.201100403 ↗
41. Microfluidic synthesis of advanced microparticles for encapsulation and controlled release10.1039/c2lc21164e ↗
42. Droplet microfluidics10.1039/b715524g ↗
43. Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs10.1021/acsnano.5b02762 ↗
44. Microfluidics as a cutting-edge technique for drug delivery applications10.1016/j.jddst.2016.01.010 ↗
45. Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention10.1002/ijc.23718 ↗
46. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats10.1158/0008-5472.CAN-05-4428 ↗
47. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells10.1002/ijc.23315 ↗
48. Adsorption of gases in multimolecular layers10.1021/ja01269a023 ↗
49. Monodisperse thermoresponsive microgels with tunable volume-phase transition kinetics10.1002/adfm.200700379 ↗
50. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles10.1016/j.jconrel.2013.05.036 ↗
51. Dual drug-loaded halloysite hybrid-based glycocluster for sustained release of hydrophobic molecules10.1039/C6RA14657K ↗
52. Caco-2 versus Caco-2/HT29-MTX Co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6 ↗